Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter

Journal of Neurochemistry

Volumn 71, Issue 3, 1998, Pages 1289-1297

  Sitte, H H ^a   Huck, S ^a   Reither, H ^a   Boehm, S ^a   Singer, E A ^a   Pifl, C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amphetamine; HEK 293 cells; Human dopamine transporter; Patch clamp; Release; Uptake

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; AMPHETAMINE; ANTIBIOTIC G 418; CARRIER PROTEIN; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; OUABAIN; SODIUM; TRITIUM; TYRAMINE;

ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ION CURRENT; MAMMAL CELL; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN TRANSPORT;

MAMMALIA; STROPHANTHUS GRATUS; TRITIUM;

EID: 0031846705     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71031289.x     Document Type: Article

References (41)

1. Bönisch H. (1984) The transport of (+)-amphetamine by the neuronal noradrenaline carrier. Naunyn Schmiedebergs Arch. Pharmacol. 327, 267-272.
2. Bönisch H. (1986) The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines. Naunyn Schmiedebergs Arch. Pharmacol. 332, 135-141.
3. Bönisch H. and Trendelenburg U. (1988) The mechanism of action of indirectly acting sympathomimetic amines, in Handbook of Experimental Pharmacology, Vol. 90(1) (Trendelenburg U. and Weiner N., eds). pp. 247-277. Springer, Berlin.
4. 3H]mazindol. J. Pharmacol. Exp. Ther. 253, 1206-1214.
5. 3H]dopamine. LiJf Sci. 42, 2553-2559.
6. Eshleman A. J., Henningsen R. A., Neve K. A., and Janowsky A. (1994) Release of dopamine via the human transporter. Mol. Pharmacol. 45, 312-316.
7. Fischer J. B. and Cho A. K. (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208, 203-209.
8. Galli A., DeFelice L. J., Duke B.-J., Moore K. R., and Blakely R. D. (1995) Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J. Exp. Biol. 198, 2197-2212.
9. Galli A., Blakely R. D., and DeFelice L. J. (1996) Norepinephrine transporters have channel modes of conduction. Proc. Natl. Acad. Sci. USA 93, 8671-8676.
10. Giros B. and Caron M. G. (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 43-49.
11. Giros B., Jaber M., Jones S. R., Wightman R. M., and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
12. Graefe K.-H. and Bonisch H. (1988) The transport of amines across axonal membranes of noradrenergic and dopaminergic neurones, in Handbook of Experimental Pharmacology, Vol. 90(I) (Trendelenburg U. and Weiner N., eds), pp. 193-245. Springer, Berlin.
13. Gu H., Wall S. C., and Rudnick G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics and ion dependence. J. Biol Chem. 269, 7124-7130.
14. Haddad P., Beck J. S., Boyer J. L., and Graf J. (1991) Role of chloride ions in liver cell volume regulation. Am. J. Physiol. 261, G340-G348.
15. 3H]catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. Neuropharmacology 12, 669-679.
16. 3H] dopamine in rat brain and tissue slices. Biochem. Pharmacol. 103, 241-248.
17. 3H]-norepinephrine in slices of rat neostriatum and cerebral cortex. J. Pharmacol. Exp. Ther. 193, 47-56.
18. Keyes S. R. and Rudnick G. (1982) Coupling of transmembrane proton gradients to platelet serotonin transport. J. Biol. Chem. 257, 1172-1176.
19. + transport. Synapse 15, 58-62.
20. Kuhar M. J., Ritz M. C., and Boja J. W. (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14, 299-302.
21. Lester H. A., Mager S., Quick M. W., and Corey J. L. (1994) Permeation properties of neurotransmitter transporters. Annu. Rev. Pharmacol. Toxicol. 34, 219-249.
22. Levi G., Roberts P. J., and Raiteri M. (1976) Release and exchange of neurotransmitters in synaptosomes: effects of the ionophore A23187 and of ouabain. Neurochem. Res. 1, 409-416.
23. Liang N. Y. and Rutledge C. O. (1982) Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem. Pharmacol. 31, 2479-2484.
24. 3H]dopamine by veratridine in pargyline-and reserpinetreated corpus striatum. Eur. J. Pharmacol. 89, 153-155.
25. Mager S., Min C., Henry D. J., Chavkin C., Hoffmann B. J., Davidson N., and Lester H. L. (1994) Conducting states of a mammalian serotonin transporter. Neuron 12, 845-859.
26. McElvain J. S. and Schenk J. O. (1992) A multisubstrate mechanism for uptake of striatal dopamine and its inhibition by cocaine. Biochem. Pharmacol. 43, 2189-2199.
27. Pifl C., Giros B., and Caron M. G. (1993) Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-pyridinium. J. Neurosci. 13, 4246-4253.
28. Pifl C., Drobny H., Reither H., Hornykiewicz O., and Singer E. A. (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol. Pharmacol. 47, 368-373.
29. Pifl C., Hornykiewicz O., Giros B., and Caron M. G. (1996) Catecholamine transporters and 1-methyl-4-phenyl-1,2,3.6-tetrahydro-pyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. J. Pharmacol. Exp. Ther. 277, 1437-1443.
30. - of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters. Br. J. Pharmacol. 121, 205-212.
31. Raiteri M., Cerrito F., Cervoni A., and Levi G. (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208, 195-202.
32. Risso S., DeFelice L. J., and Blakely R. D. (1996) Sodium-dependent GABA-induced currents in GAT1-transfected HeLa cells. J. Physiol. (Lond.) 490, 691-702.
33. Ritter M., Woll E., Haussinger D., and Lang F. (1992) Effects of bradykinin on cell volume and intracellular pH in NIH 3T3 fibroblasts expressing the ras oncogene. FEBS Lett. 307, 367-370.
34. Ross S. B. and Renyi A. L. (1966) Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro. Acta Pharmacol. Toxicol. (Copenh.) 24, 297-309.
35. Singer E. A. and Pifl C. (1998) A superfusion study on the mechanism of carrier-mediated release in cells stably expressing the cloned human dopamine transporter. Naunyn Schmiedebergs Arch. Pharmacol. 357, R26.
36. Sonders M. S. and Amara S. G. (1996) Channels in transporters. Curr. Opin. Neurobiol. 6, 294-302.
37. Sonders M. S., Zhu S.-J., Zahniser N. R., Kavanaugh M. P., and Amara S. G. (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17, 960-974.
38. Trendelenburg U. (1972) Classification of sympathetic amines, in Handbook of Experimental Pharmacology, Vol. 32 (Blaschko H. and Muscholl E., eds), pp. 336-362. Springer, Berlin.
39. Wall S. C., Gu H., and Rudnick G. (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol. Pharmacol. 47, 544-550.
40. Yamazaki T., Akiyama T., Kitagawa H., Takeuchi Y., and Kawada T. (1996) Elevation of either axoplasmic norepinephrine or sodium level induced release of norepinephrine from cardiac sympathetic nerve terminals. Brain Res. 737, 343-346.
41. 3H]amphetamine with rat brain synaptosomes. II. Active transport. J. Pharmacol. Exp. Ther. 257, 830-835.